CMS certification 030013
Yuma Regional Medical Center
2400 South Avenue a, Yuma, AZ 85364
Yuma Regional Medical Center has a CMS overall rating of 2 out of 5 stars. 63% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 1 and worse on 3. Emergency patients spend a median of 3 h 12 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,342 completed surveys, 22% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | AZ | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 376 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 12 min | 2 h 56 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 14 visits sampled | 6 h 49 min | 4 h 33 min | 4 h 17 min |
| Left before being seen Lower is better · 96,203 patients | 3% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 56 patients | 80% | 70% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 139 patients | 53% | 59% | 65% |
How Yuma Regional Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Yuma Regional Medical CenterThis hospital | 2/5 | 63% | 3 h 12 min | 1 better 3 worse |
| Exceptional Community Hospital YumaSame city | Not rated | 77% | — | No different |
| Banner del E. Webb Medical CenterSame ZIP area · Sun City West | 3/5 | 59% | 3 h 50 min | 2 better 2 worse |
| Banner Boswell Medical CenterSame ZIP area · Sun City | 3/5 | 62% | 3 h 44 min | 3 better 5 worse |
| La Paz Regional HospitalSame ZIP area · Parker | 2/5 | 68% | — | No different |
| Dignity Health - Arizona General HospitalSame ZIP area · Laveen | Not rated | 73% | 1 h 44 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Yuma.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 3,722 cases | Too few cases | 4.8% | 3.9% |
| Heart attack 302 cases | Too few cases | 13.4% | 11.9% |
| Heart failure 456 cases | Too few cases | 12.3% | 11.1% |
| Pneumonia 627 cases | Too few cases | 17.2% | 15.2% |
| Stroke 296 cases | Too few cases | 16% | 11.9% |
| COPD 154 cases | Too few cases | 11.8% | 8.6% |
| Heart bypass surgery (CABG) 84 cases | Too few cases | 4% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.91 likely 0.59 – 1.24 | 1 |
| After hip or knee replacement 26 cases | Too few cases | 4% | 4.1% |
| Deaths after a serious but treatable surgical complication 70 cases | Worse | 223.03 per 1,000 likely 174.74 per 1,000 – 271.32 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 4,890 cases | No different | 0.37 per 1,000 likely 0 per 1,000 – 1.06 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 5,914 cases | No different | 0.21 per 1,000 likely 0 per 1,000 – 0.42 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 6,115 cases | No different | 0.23 per 1,000 likely 0.03 per 1,000 – 0.42 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,494 cases | No different | 2.1 per 1,000 likely 0.65 per 1,000 – 3.55 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 438 cases | No different | 1.43 per 1,000 likely 0 per 1,000 – 3.04 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 451 cases | No different | 10.77 per 1,000 likely 3.99 per 1,000 – 17.55 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,577 cases | No different | 2.42 per 1,000 likely 0.37 per 1,000 – 4.48 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 415 cases | No different | 5.6 per 1,000 likely 1.75 per 1,000 – 9.45 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 329 cases | No different | 1.63 per 1,000 likely 0.16 per 1,000 – 3.1 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,120 cases | No different | 1.49 per 1,000 likely 0.53 per 1,000 – 2.45 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.9 likely 0.42 – 1.71 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.77 likely 0.31 – 1.59 | 1 |
| Surgical site infections after colon surgery | No different | 0.83 likely 0.26 – 1.99 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0 | 1 |
| MRSA bloodstream infections | No different | 0.62 likely 0.1 – 2.05 | 1 |
| C. diff intestinal infections | Better | 0.12 likely 0.04 – 0.28 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 405 cases | Too few cases | 13.4% | 14.4% |
| Readmitted after heart failure 661 cases | Too few cases | 21.8% | 21.3% |
| Readmitted after pneumonia 939 cases | Too few cases | 17.9% | 17.3% |
| Readmitted after COPD 216 cases | Too few cases | 19.1% | 20% |
| Readmitted after heart bypass surgery 93 cases | Too few cases | 12.3% | 11% |
| Days back in hospital after a heart attack 291 cases | Too few cases | -9.4 days per 100 | — |
| Days back in hospital after heart failure 506 cases | Too few cases | 36.5 days per 100 | — |
| Days back in hospital after pneumonia 644 cases | Too few cases | 7 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 2,778 cases | No different | 14 per 1,000 likely 11.2 per 1,000 – 17.3 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 327 cases | No different | 12.6 per 100 likely 9.8 per 100 – 15.8 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 327 cases | No different | 6.1 per 100 likely 4.5 per 100 – 8.3 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 940 cases | No different | 1.2 likely 0.9 – 1.4 | — |
2 more measures had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $148,360
- 2020 $144,715
- 2021 $331,139
- 2022 $164,889
- 2023 $180,139
- 2024 $273,478
- 2025 $280,304
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $6,798 | 7 |
| Debt forgiveness | $1,570 | 1 |
| Space rental and facility fees | $1,149 | 2 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $73,882 | 52 |
| AstraZeneca UK Limited | $68,070 | 1 |
| AstraZeneca Pharmaceuticals LP | $35,184 | 1 |
| Merck Sharp & Dohme LLC | $33,210 | 1 |
| Spectrum Pharmaceuticals Inc. | $15,100 | 1 |
| Genentech, Inc. | $14,642 | 1 |
| Novartis Pharmaceuticals Corporation | $12,597 | 1 |
| Abbvie INC. | $12,378 | 6 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase III Double-Blind Randomised Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel… AstraZeneca UK Limited | $68,070 |
| A RANDOMIZED, DOUBLE-BLIND PHASE 2/3 STUDY OF FIANLIMAB (ANTI-LAG-3 ANTIBODY), CEMIPLIMAB (ANTI-PD-1 ANTIBODY), AND CHEMOTHERAPY VERSUS CEMIPLIMAB AN… Regeneron Pharmaceuticals, Inc. · NCT05800015 | $44,929 |
| A Phase III Randomized Open-Label Sponsor-Blinded Multicenter Study of Durvalumab in Combination with Tremelimumab Lenvatinib Given Concurrently wit… AstraZeneca Pharmaceuticals LP | $35,184 |
| A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 mRNA-4157 Plus Pembrolizumab Versus Ad… Merck Sharp & Dohme LLC | $33,210 |
| A RANDOMIZED, DOUBLE-BLIND PHASE 2/3 STUDY OF FIANLIMAB (ANTI-LAG-3 ANTIBODY) IN COMBINATION WITH CEMIPLIMAB (ANTI-PD-1 ANTIBODY) VERSUS CEMIPLIMAB M… Regeneron Pharmaceuticals, Inc. · NCT05785767 | $28,953 |
| SPI-GCF-104 Spectrum Pharmaceuticals Inc. | $15,100 |
| Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC Genentech, Inc. | $14,642 |
| A Randomized, Double-blind, Placebo-controlled Phase III Multi-center Study of Azacitidine With or Without MBG453 for the Treatment of Patients With … Novartis Pharmaceuticals Corporation | $12,597 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Yuma Regional Medical Center
Is Yuma Regional Medical Center a good hospital?
Yuma Regional Medical Center has a CMS overall rating of 2 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 1 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Yuma Regional Medical Center?
63% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,342 completed HCAHPS surveys.
How long is the wait in the Yuma Regional Medical Center emergency room?
Emergency patients spend a median of 3 h 12 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Yuma Regional Medical Center receive money from drug and device companies?
Drug and device makers reported $280,304 in payments to Yuma Regional Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.